Your browser doesn't support javascript.
loading
A novel EML4-ALK BIRC6-ALK double fusion variant in lung adenocarcinoma confers sensitivity to alectinib.
Zhong, Jiang-Ming; Zhang, Gui-Feng; Lin, Li; Li, De-Yu; Liu, Zhen-Hua.
Afiliação
  • Zhong JM; Department of Medical Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, PR China.
  • Zhang GF; Department of Medical Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, PR China.
  • Lin L; Department of Medical Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, PR China.
  • Li DY; Department of Medical Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, PR China.
  • Liu ZH; Department of Medical Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, PR China. Electronic address: liuzhenhua6909@163.com.
Lung Cancer ; 145: 211-212, 2020 07.
Article em En | MEDLINE | ID: mdl-32409002

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article